Where does Surgery Partners, Inc.'s cash flow data come from?

Every line is extracted from Surgery Partners, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	$97.1M+231%	$98.9M+300%	-$38.6M-136%	-$57.5M-145%	-$74M-147%
Depreciation and amortization	$178.2M+14.8%	$176M+15.3%	$150M+0.1%	$160.7M+25.1%	$155.2M+31.4%
Stock-based compensation	——	——	$23.2M-26.6%	$27.7M-4.2%	$36M+95.7%
Deferred income taxes	$15.7M-87.8%	$16.7M-87.3%	$124.5M—	$122.1M—	$128.7M—
Change in accounts receivable	$55M-24.3%	$53.8M-25.4%	$48.6M-19.3%	$51.5M-5.0%	$72.7M+43.7%
Other working capital changes	——	——	——	——	——
Distributions from equity method investments	-$700K-137%	$800K-60.0%	$1.3M—	$2M—	$1.9M—
Net cash from operating activities	$280M+5.5%	$274.3M-8.6%	$282.3M+12.3%	$263.9M-9.2%	$265.4M+2.1%
Capital expenditures	$72M-21.8%	$78.7M-12.9%	$88.2M+0.3%	$88.6M+2.3%	$92.1M+7.7%
Acquisitions, net of cash acquired	$122.3M-66.8%	$162.1M-57.2%	$140.2M-56.5%	$162.2M-46.1%	$368.2M+292%
Proceeds from sale of businesses	$41.7M—	$46.5M—	$44M—	——	——
Other investing activities	$23.9M-16.1%	$40.5M+63.3%	$35M+22.0%	$25.6M-2.3%	$28.5M-22.1%
Purchases of equity securities	——	——	——	——	——
Proceeds from sales of equity securities	$2.4M—	$1.5M—	$600K—	——	——
Net cash from investing activities	-$185.7M+61.5%	-$248.7M+49.1%	-$234.3M+46.1%	-$237.7M+42.2%	-$481.8M-102%
Proceeds from issuance of debt	$1.18B-32.4%	$1.2B-30.5%	$776M-64.3%	$816.5M-61.0%	$1.75B+74.5%
Repayments of debt	$1.11B-12.8%	$1.04B-18.7%	$630.9M-65.1%	$604.9M-65.4%	$1.28B+40.3%
Distributions to noncontrolling interests	$221.7M+15.3%	$226M+32.6%	$216.9M+37.7%	$206.1M+37.5%	$192.3M+32.9%
Other financing activities	$13.3M+191%	$9.4M+175%	-$1.8M+82.9%	-$8.9M+16.8%	-$14.6M-33.9%
Payment of debt issuance costs	$4.5M-70.2%	$4.1M-72.8%	$1.6M-95.8%	$200K-99.5%	$15.1M-34.3%
Net cash from financing activities	——	——	-$68.5M-139%	$15.6M-90.0%	$267.8M+425%
Net increase (decrease) in cash	——	——	——	——	$44.1M—
Interest paid	——	$256.8M+28.6%	$242.53M+26.2%	$228.25M+23.6%	$213.98M+20.8%
Income taxes paid	——	$1.2M-25.0%	$1.3M-16.1%	$1.4M-6.7%	$1.5M+3.4%
Gain (Loss) On Disposition Of Assets And Deconsolidation	-$28.3M+37.8%	-$30.4M+25.1%	-$38.1M-34.2%	-$37.2M-90.8%	-$45.5M-743%
Income Loss From Equity Method Investments Net Of Dividends Or Distributions	-$700K-137%	$800K-60.0%	$1.3M—	$2M—	$1.9M—
Noncash Interest Income (Expense), Net	-$9.4M-25.3%	-$9.6M-47.7%	-$7.9M+21.0%	-$7.4M+50.7%	-$7.5M+62.5%
Payment for (Proceeds from) Other Investing Activity	$23.9M-16.1%	$40.5M+63.3%	$35M+22.0%	$25.6M-2.3%	$28.5M-22.1%
Payments to Acquire Equity Method Investments	——	——	——	——	——
Sales of and distributions from equity method investments	$2.4M—	$1.5M—	$600K—	——	——
Proceeds from disposition of property, plant and equipment/other	$41.7M—	$46.5M—	$44M—	——	——
Payments Of Debt Issuance Costs	$4.5M-70.2%	$4.1M-72.8%	$1.6M-95.8%	$200K-99.5%	$15.1M-34.3%
Other, net	$13.3M+191%	$9.4M+175%	-$1.8M+82.9%	-$8.9M+16.8%	-$14.6M-33.9%
Proceeds From Payments To Minority Shareholders	——	——	——	$11.7M+30.0%	$10.3M—
Operating Lease Expense	$39.4M-0.3%	$37.8M-2.8%	$38.8M+2.1%	$39.7M+10.3%	$39.5M+12.2%
Income Taxes Paid, Net	——	$1.2M-25.0%	$1.3M-16.1%	$1.4M-6.7%	$1.5M+3.4%
Free cash flow	$208M+20.0%	$195.6M-6.7%	$194.1M+18.8%	$175.3M-14.1%	$173.3M-0.7%
Free cash flow	$208M+20.0%	$195.6M-6.7%	$194.1M+18.8%	$175.3M-14.1%	$173.3M-0.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Surgery Partners, Inc.'s cash flow data come from?: Every line is extracted from Surgery Partners, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.